NTNX vs. RXST
NTNX (Nutanix, Inc.) and RXST (RxSight, Inc.) are both stocks. NTNX operates in Software - Infrastructure (Technology), while RXST operates in Medical Devices (Healthcare). Over the past 3 years, NTNX returned 22.88%/yr vs -42.05%/yr for RXST. At a 0.22 correlation, their price movements are largely independent.
Performance
NTNX vs. RXST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NTNX achieves a 6.35% return, which is significantly higher than RXST's -51.06% return.
NTNX
- 1D
- 3.64%
- 1M
- 26.57%
- YTD
- 6.35%
- 6M
- 16.68%
- 1Y
- -28.74%
- 3Y*
- 22.88%
- 5Y*
- 10.43%
- 10Y*
- —
RXST
- 1D
- 6.47%
- 1M
- -29.75%
- YTD
- -51.06%
- 6M
- -59.17%
- 1Y
- -66.58%
- 3Y*
- -42.05%
- 5Y*
- —
- 10Y*
- —
NTNX vs. RXST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
NTNX Nutanix, Inc. | 6.35% | -15.51% | 28.29% | 83.07% | -18.24% | -11.55% |
RXST RxSight, Inc. | -51.06% | -69.69% | -14.73% | 218.23% | 12.62% | -29.69% |
Correlation
The correlation between NTNX and RXST is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Aug 2, 2021 | 0.22 |
The correlation between NTNX and RXST shifts across timeframes, from 0.07 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.
Fundamentals
NTNX:
$16.05B
RXST:
$210.66M
NTNX:
$0.93
RXST:
-$1.14
NTNX:
5.90
RXST:
1.64
NTNX:
$2.75B
RXST:
$127.48M
NTNX:
$2.39B
RXST:
$98.18M
NTNX:
$293.53M
RXST:
-$50.09M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NTNX vs. RXST — Risk / Return Rank
NTNX
RXST
NTNX vs. RXST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutanix, Inc. (NTNX) and RxSight, Inc. (RXST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NTNX | RXST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.28 | ||
| Sortino ratioReturn per unit of downside risk | +0.71 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.82 | +0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.50 | -0.96 | +0.46 |
| Martin ratioReturn relative to average drawdown | -0.84 | -1.47 | +0.63 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NTNX | RXST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.63 | -0.90 | +0.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.21 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | -0.31 | +0.38 |
Drawdowns
NTNX vs. RXST - Drawdown Comparison
The maximum NTNX drawdown since its inception was -80.40%, smaller than the maximum RXST drawdown of -92.55%. Use the drawdown chart below to compare losses from any high point for NTNX and RXST.
Loading charts...
Drawdown Indicators
| NTNX | RXST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.40% | -92.55% | +12.15% |
Max Drawdown (1Y)Largest decline over 1 year | -57.58% | -69.47% | +11.89% |
Max Drawdown (3Y)Largest decline over 3 years | -58.58% | -92.55% | +33.97% |
Max Drawdown (5Y)Largest decline over 5 years | -68.71% | — | — |
Current DrawdownCurrent decline from peak | -33.83% | -92.07% | +58.24% |
Average DrawdownAverage peak-to-trough decline | -40.59% | -36.66% | -3.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.13% | 45.33% | -11.20% |
Volatility
NTNX vs. RXST - Volatility Comparison
The current volatility for Nutanix, Inc. (NTNX) is 16.60%, while RxSight, Inc. (RXST) has a volatility of 22.33%. This indicates that NTNX experiences smaller price fluctuations and is considered to be less risky than RXST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NTNX | RXST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.60% | 22.33% | -5.73% |
Volatility (6M)Calculated over the trailing 6-month period | 35.59% | 44.65% | -9.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.98% | 73.98% | -28.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.71% | 69.15% | -19.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 57.17% | 69.15% | -11.98% |
Dividends
NTNX vs. RXST - Dividend Comparison
Neither NTNX nor RXST has paid dividends to shareholders.
Financials
NTNX vs. RXST - Financials Comparison
This section allows you to compare key financial metrics between Nutanix, Inc. and RxSight, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NTNX vs. RXST - Profitability Comparison
NTNX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported a gross profit of 610.68M and revenue of 703.07M. Therefore, the gross margin over that period was 86.9%.
RXST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported a gross profit of 23.50M and revenue of 30.89M. Therefore, the gross margin over that period was 76.1%.
NTNX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported an operating income of 68.56M and revenue of 703.07M, resulting in an operating margin of 9.8%.
RXST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported an operating income of -17.83M and revenue of 30.89M, resulting in an operating margin of -57.7%.
NTNX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nutanix, Inc. reported a net income of 72.09M and revenue of 703.07M, resulting in a net margin of 10.3%.
RXST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RxSight, Inc. reported a net income of -15.88M and revenue of 30.89M, resulting in a net margin of -51.4%.
Frequently Asked Questions
NTNX and RXST have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXST has higher volatility (22.33%) compared to NTNX (16.60%). In terms of maximum drawdown, NTNX dropped -80.40% vs RXST's -92.55%.
NTNX currently has the higher Sharpe Ratio (-0.63 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NTNX and RXST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer